Wegovy in India 2026: Cost, Availability, Results & Honest Risks

Quick answer: Wegovy (semaglutide 2.4mg, Novo Nordisk's purpose-built weight-loss brand) launched in India in June 2025 and is available on prescription. After a price cut in late 2025 it costs roughly ₹10,850-16,400/month depending on dose (always confirm the current MRP with your doctor or pharmacy). Results: 10-15% body weight loss average over 12 months, with a 25-40% muscle-loss risk if you do not strength-train. The semaglutide patent expired in India in March 2026, so generic versions are arriving through 2026 and are expected to push prices down further.

Wegovy vs Ozempic: What's the Difference?

Wegovy and Ozempic are the SAME DRUG (semaglutide) but with different labels and dosing. Ozempic is approved in India for type 2 diabetes at lower doses (0.25-2.0 mg); Wegovy is Novo Nordisk's weight-loss brand, dosed higher (up to 2.4 mg per weekly injection) and labelled specifically for obesity / weight management.

In practice: with Wegovy now available in India, your doctor can prescribe semaglutide on-label for weight loss, instead of prescribing Ozempic off-label as was common before mid-2025. The drug and results are essentially identical to Ozempic - Wegovy is simply the higher-dose, weight-loss-labelled version of the same molecule.

Wegovy Availability in India (Current Status 2026)

Wegovy launched in India in June 2025 and is available on prescription. Here is what that means for you:

• Pharmacy access: Available with a doctor's prescription through Indian pharmacies (subject to stock and dose).
• Price: Roughly ₹10,850-16,400/month after Novo Nordisk's late-2025 price cut (varies by dose - always confirm the current MRP).
• Generics coming: The semaglutide patent expired in India in March 2026, so 40+ Indian generic versions are launching through 2026 and are expected to lower prices significantly.
• Alternatives: Ozempic (same molecule, diabetes-labelled) and Mounjaro (tirzepatide, Eli Lilly, launched March 2025) are also available.

With generic semaglutide entering the market and Novo Nordisk responding via price cuts and a higher-dose Wegovy HD, GLP-1 access in India is widening fast and getting cheaper - a big shift from the off-label-Ozempic-only era of 2024.

Wegovy Cost in India (2026)

After Novo Nordisk's late-2025 price cut, Wegovy in India costs roughly:

• Per month (starter / step-up doses): ₹10,850-13,000 (0.25-1.0 mg phases)
• Per month (maintenance): up to ₹16,400 (higher doses up to 2.4 mg)
• Annual: roughly ₹1.3-2.0 lakh (likely to fall as generics arrive)

Novo Nordisk cut Wegovy's India price by up to about 37% in November 2025. With generic semaglutide launching through 2026, expect prices to drop further. Always confirm the current MRP with your doctor or pharmacy before budgeting.

Wegovy Results: Realistic Expectations

Weight Loss Timeline

Because Wegovy uses semaglutide (same as Ozempic), the results are virtually identical:

• Month 1-4: Appetite drops sharply. Gradual loss of 5-8 kg as you adjust.
• Month 5-8: At full 2.4 mg dose, weight loss accelerates. 8-12 kg over these months.
• Month 9-12: Plateau phase. Loss slows to 0.5-1 kg/week. Year-end total: 15-20 kg average.

% body weight loss: 10-15% over 12 months — same efficacy class as Ozempic, just branded and dosed higher for weight loss specifically.

The Muscle Loss Reality

Like all GLP-1 drugs, 25-40% of Wegovy-driven weight loss is lean muscle without protective strength training. Semaglutide suppresses appetite indiscriminately — you eat less protein, less calories, everything. Result: your body breaks down muscle along with fat.

The fix is identical to Ozempic:

• 3-4 strength sessions/week: Compound movements (squats, deadlifts, presses, rows).
• 1.8-2.2 g protein per kg body weight: Paneer, eggs, dal, chicken, whey. Non-negotiable.
• Hydration: 3.5-4L water daily.

With these in place, you preserve 60-75% of your weight loss as pure fat.

Wegovy Side Effects: India Perspective

Common

• Nausea (30-40%): Strongest weeks 1-4, fades by week 8 for most. Eat small meals; avoid greasy/spicy.
• Constipation (20-30%): Slowed gut motility. 3-4L water + high-fiber Indian foods (leafy greens, whole grains).
• Fatigue (10-20%): Calorie deficit + new drug. Improves with adequate protein and sleep.

India-Specific (Deficiency-Related)

Most Indians have baseline vitamin D, B12, iron deficiency. Wegovy amplifies:

• Hair loss (15-25%): Reduced calories + low B12/ferritin + stress. Get ferritin, B12, folate checked at month 2. B12 injections (₹500/month) help.
• Electrolyte imbalance: Dehydration risk. Drink consistently and monitor salt intake.

Serious (Rare)

• Pancreatitis: Severe upper abdominal pain = stop and seek emergency care.
• Acute kidney injury: Rare; hydration is preventive.

Who Should NOT Take Wegovy (Even If Available)

• Personal or family history of medullary thyroid cancer: GLP-1 black-box warning.
• Severe kidney disease: eGFR below 30 = risk of acute injury.
• Acute or chronic pancreatitis history: Risk of flare-up.
• Pregnant, planning pregnancy, or breastfeeding: Limited safety data; stop 3 months before conception.
• Severe eating disorders or dehydration: Risk amplified; needs psychiatric support first.

Mounjaro vs Ozempic vs Wegovy: Your Realistic Choice Today

For Indians in 2026, your options are:

• Ozempic (semaglutide): Available now, ₹16-25K/month, proven, widely prescribed.
• Mounjaro (tirzepatide): Available now (since March 2025), ₹14-25K/month, slightly stronger results (14-22% vs 10-15%).
• Wegovy (semaglutide 2.4mg): NOT available in India; may launch in 2027 or later.

If you want weight-loss-specific semaglutide, your doctor can prescribe Ozempic off-label. If you want something stronger, Mounjaro is your best bet. Wegovy remains a future option.

The Full Cost Picture

Budget for a realistic year on Wegovy:

• Wegovy (₹10,850-16,400/month): ₹1.3-2.0 lakh
• Doctor visits (4-6/year): ₹10-18K
• Labs (baseline + 3 follow-ups): ₹10-15K
• B12 + supplements: ₹5-12K
• Nutrition coaching (optional): ₹12-36K
• Strength training: ₹15-36K

Realistic total: ₹2.5-3.5 lakh.

FAQ: Wegovy in India

Q: Is Wegovy available in India in 2026?

A: Yes. Novo Nordisk launched Wegovy in India in June 2025, and after a late-2025 price cut it costs about ₹10,850-16,400/month depending on dose. Ozempic (the same molecule at lower doses) is also available, and generic semaglutide is arriving in 2026 now that the patent has expired.

Q: Why isn't Wegovy in India?

A: Novo Nordisk may be waiting for regulatory clarity, market size assessment, or pricing strategy. Mounjaro's launch (March 2025) may have also influenced their timeline. No official launch date has been announced.

Q: Can I import Wegovy to India?

A: Technically possible via international pharmacy fills, but it's a legal grey area. Customs may flag it; authenticity risks exist. Most Indian doctors recommend Ozempic (available legally) instead.

Q: Is Wegovy better than Ozempic?

A: They are the same drug. Wegovy uses a higher standard dose (2.4 mg), Ozempic uses lower doses. Results are similar. Wegovy's advantage is weight-loss-specific labeling; Ozempic's advantage is availability in India.

Q: How does Mounjaro compare to Wegovy?

A: Mounjaro (tirzepatide) is a different drug (dual GLP-1/GIP agonist). It typically produces 14-22% weight loss vs semaglutide's 10-15%. Mounjaro IS available in India now. Side effects are similar. See our full Mounjaro vs Ozempic vs Wegovy comparison.

Related Reads

• Ozempic in India 2026: Cost, Where to Get It, Results & Honest Risks
• Mounjaro in India 2026: Full Cost, Results, Side Effects — The Honest Guide
• Mounjaro vs Ozempic vs Wegovy in India 2026: Which Is Best?
• Best Indian Diet on GLP-1 (Mounjaro/Wegovy): High-Protein Protocol
• YourTrainer GLP-1 Coaching

- Coach Anish, YourTrainer · Lifestyle coaching content, not medical advice. Always consult your doctor.